Susanne Preithner

Statistics

Publications

Citations

395

H-Index

Active since

2001

Affiliations

Ludwig-Maximilians-Universität München(Current)

Susanne Preithner is an author at Ludwig-Maximilians-Universität München specializing in therapeutic antibody development, monoclonal antibody therapy, and antibody-dependent cellular cytotoxicity.

Publications per year

2001–2005

Publications

Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines

Nadja Prang, Susanne Preithner, Klaus Brischwein et al. · British Journal of Cancer · 2005 · 143 citations · Full text

Pharmacy, Oncology, Pharmacology +17

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Susanne Preithner, Stefanie Elm, Sandra Lippold et al. · Molecular Immunology · 2005 · 131 citations · Full text

Pharmacy, Immunology, Antibody Engineering +13

In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment

Stefanie Naundorf, Susanne Preithner, Petra Mayer et al. · International Journal of Cancer · 2002 · 100 citations · Full text

Pharmacy, Immunology, Oncology +17

Biomonitoring of pJP4‐carrying Pseudomonas chlororaphis with Trb protein‐specific antisera

Heike Schmidt‐Eisenlohr, Michael Rittig, Susanne Preithner et al. · Environmental Microbiology · 2001 · 21 citations

Life Sciences, Microbiology, Molecular Biology +14

1–4 of 4